Abstract
TGFBIp/βig-h3 protein is an extracellular matrix molecule initially cloned from human adenocarcinoma cells treated with TGF-β. Its precise function remains obscure but a number of studies have demonstrated it to be an intriguingly versatile molecule role in a wide range of physiological and pathological conditions. To date, the most extensively studied and reported action of TGFBIp/βig-h3 protein is in corneal dystrophy and several excellent reviews are available on this. Work from various laboratories on this molecule has compiled a tremendous amount of information over the past decade and a half. Here we review the current understanding on TGFBIp/βig-h3 protein and its functions in morphogenesis, extracellular matrix interactions, adhesion/migration, corneal dystrophy, tumorigenesis, angiogenesis, nephropathies, osteogenesis, wound healing and inflammation.
Original language | English |
---|---|
Pages (from-to) | 2183-2194 |
Number of pages | 12 |
Journal | International Journal of Biochemistry and Cell Biology |
Volume | 39 |
Issue number | 12 |
DOIs | |
Publication status | Published - 2007 |
Externally published | Yes |
Keywords
- Angiogenesis
- Cell adhesion
- FAS1 domain
- Inflammation
- Integrin
- Nephropathy
- Osteogenesis
- TGFBI
- Tumorigenesis
- Wound healing
- βig-h3
ASJC Scopus subject areas
- Biochemistry
- Cell Biology